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Background: Lymph node (LN) metastases are a major negative prognostic factor for peri-hilar cholan-
giocarcinoma (PCC). Prognostic significance of the extent of LN dissection, number of metastatic LN and
the lymph node ratio (LNR) are still under debate.
Aims: The aims of the present study were to evaluate the prognostic value of the LN status, the total
number of LNs evaluated and LNR in PCC.
Methods: Between 1990 and 2008, 62 patients with PCC submitted to surgical resection with curative
intent were retrospectively evaluated. Number and status of harvested LN were recorded.
Results: In 53 patients (85.4%) regional lymphadenectomy was performed. Median number of LNs
examined was 7 (range 1–25). Median survival was 41.9 months in patients with N0 compared with 22.7
months in 21 patients (39.6%) with N+ (P = 0.03). Median survival was 3, 18.5 and 29 months for patients
with 0, 1–3 and >3 LN retrieved, respectively (P < 0.01). Five-year survival for patients above and below
the LNR cut-off value of 0.25 was 0% and 22.5%, respectively (P = 0.03).
Conclusions: LN metastases are a major prognostic factor for survival after surgical resection of PCC.
The number of LN harvested and LNR showed high prognostic value.
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Introduction
Cholangiocarcinoma is a rare but increasing worldwide tumour,
originating from either intra- or extrahepatic bile.1 Accordingly it
is classified by its origin into intrahepatic (ICC), peri-hilar (PCC)
or extrahepatic (EHC) cholangiocarcinoma.2 Surgical treatment
with radical intent is the only therapeutic option which has been
shown to prolong survival.3 Several prognostic factors have been
evaluated for cholangiocarcinoma. Among these, lymph node
metastases is one of the most important prognostic factors.
Several clinical studies described shorter survival in patients with
positive lymph nodes, with a 5-year survival of 0–20%.4–8
The extent of lymph node dissection and its prognostic value is
still a matter of debate in the literature. Moreover the lymph node
ratio (LNR) has been evaluated for different gastrointestinal
tumours and has been shown to give greater prognostic stratifi-
cation for patients with positive lymph nodes.9–11 Currently,
within the literature there is only one study that evaluated LNR in
cholangiocarcinoma.12 This was limited to a cohort of patients
with intrahepatic cholangiocarcinoma and hence no studies exist
for peri-hilar cholangiocarcinoma.
The aims of the present study were to evaluate, in a cohort of
patients submitted to surgical resection with curative intent for
perihilar cholangiocarcinoma, the relationship between lymph
nodes status and survival, the prognostic significance of the total
number of resected lymph nodes and to evaluate the prognostic
significance of the LNR.
This paper was presented at the International Hepato-Pancreato-Biliary
Association Annual Meeting, 18–22 April 2010, Buenos Aires, Argentina.
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Methods
Retrospective analysis of sixty-two patients with PCC who under-
went surgery with curative intent between 1990 and 2008 in a
single Divisions of Surgery at University of Verona were included
in the study. Written informed consent was obtained from each
patient.
Pre-operative evaluation included blood chemistry tests with
AST, ALT, ALP, GGT, direct and total bilirubin, blood count, PT,
aPTT, albumin, CEA, CA19.9, alpha-fetoprotein and serology for
hepatitis viruses (HBV and HCV). The tumour extension was
evaluated with ultrasonography (US), colour Doppler ultra-
sonography, computed tomography (CT) or magnetic resonance
imaging (MRI). The differential diagnosis between cholangiocar-
cinoma and gastro-intestinal tumours liver metastases was
made with tumour histology and by exclusion of other
primary tumours using esophagogastroduodenoscopy and
colonoscopy.
In patients with obstructive jaundice, the extension of the
tumour was assessed using different diagnostic methods during
the study period. Between 1990 and 1997, all of the patients
underwent percutaneous trans-hepatic cholangiography (PTC)
with the placement of single or multiple biliary drains; subse-
quently, mainly non-invasive diagnostic methods such as
colangio-pancreatography MRI were used. All of the patients with
obstructive jaundice (serum bilirubin level higher than 3 mg/dl)
underwent percutaneous biliary drainage in order to define more
precisely the longitudinal extension of the tumour and to resolve
obstructive jaundice. In patients with segmental cholangitis mul-
tiple hepatic drainages of the excluded biliary segments were per-
formed. More recently the use of CT-PET and diagnostic
laparoscopy was introduced in selected patients.
During surgery, intra-operative US was routinely used in order
to confirm pre-operative diagnosis, to evaluate the relationship
between tumour and blood vessel and to evaluate the presence of
intrahepatic metastases. The extent of liver resection was defined
according to the Brisbane classification.13 Peri-operative death was
defined as death within 30 days of the operation or at any point
during the index hospitalization.
Lymphadenectomy of the regional lymph nodes was classified
according to the classification of the Japanese Society of Biliary
Surgery.14 Lymph nodes of the hepatoduodenal ligament (12h,
12a, 12p, 12b), the proper hepatic artery (8) and of the posterior
surface of the head of the pancreas (13) were routinely dissected
and retrieved; interaortocaval lymph nodes were retrived when
macroscopically abnormal. The surgical technique included com-
plete dissection of the hilar structures, all the fatty and lymph
node tissue sorrounding the common hepatic artery, the main
portal vein and the bile buct.
For the purposes of the present study, PCC was defined as
tumours with involvement of structures of the hepatic hilus that
often had required resection of the biliary confluence associated
with liver and caudate lobe resection.7,15
Microscopical invasion of the bile duct wall, the portal
pedicle and the neural tissue was evaluated in each surgical
specimen.
Vascular invasion was defined as neoplastic invasion of the
arterial, portal or hepatic vessels confirmed by pathological
examination.
After surgery patients were regularly followed up with blood
tests, tumour markers (CEA and CA19.9) and an abdominal CT
scan every 6 months.
From 2000 after surgery patients with lymph node metastases
(N+) received adjuvant chemotherapy; adjuvant radiotherapy was
reserved for patients with positive resection margins (R+).
Statistical analysis
The study data were prospectively collected and retrospectively
analysed using SPSS statistical software (version 16.0; SPSS, Inc.,
Chicago, IL, USA). The hypothesis about the lack of an associa-
tion between categorical variables was tested using Pearson’s chi-
squared test. Survival was modelled by means of a multivariate
Cox’s regression model. Factors that enter the model were
selected using the univariate log-rank test. An association
between selected factors and survival was graphically analysed
using Kaplan–Meier curves. P-values < 0.05 were considered sta-
tistically significant.
Results
Sixty-two patients submitted to surgical resection for PCC
with curative intent, from 1990 to 2008, were included in
the present study. Clinical characteristics are summarized in
Tables 1 and 2.
Radical resection (R0 resection) was obtained in 46 patients
(76.7%). In 16 patients with positive margin resection (R1) tumor
involved the proximal bile duct in 12, the distal bile duct in 2 and
the liver parenchyma in 2.
Table 1 Patients characteristics
Variable (n = 62) n (%)
Median age (range) 66 (30–84)
Median CA19.9 U/ml (range) 132 (9–6835)
Bile duct resection 62 (100)
Associated liver resection 54 (87)
Major hepatectomy 51 (82)
Caudate lobe resection 47 (76)
Portal vein resection/reconstruction 10 (16)
Hepatic artery resection/recontruction 2 (3)
Regional lymph node dissection 53 (85)
Perineural invasion 50 (81)
Vascular invasion 35 (56)
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Hospital mortality and morbidity were observed in 9.6% (6/62
patients) and 55% (34/62 patients), respectively; mortality was to
2/41 patients for time period 2000–08.
Regional lymphadenectomy was performed in 53 patients
(85.4%), with a median number of harvested LN in this group of
7 (range 1–25).
LN metastases were present in 21 patients (39.6%).
According to Japanese Society of Biliary Surgery14 classifi-
cation LN metastases involved the N1 station in 21/53 patients
(39.6%), the N2 station in 6/16 patients and the N3 station
in 3/14.
Median follow-up for 56 (90.4%) patients who survived
surgery was of 18.5 months (range 6–67 months).
Median survival was 21.9 months [95% confidence interval
(CI) 18–26], with actuarial 3- and 5-year survival of 30% and
15%, respectively.
Survival analysis by LN status, number of LNs retrieved,
number of positive LNs and LNR are shown in Table 3 and
Figures 1–3.
Survival was not significantly different in patients with LN
metastases in the N1, N2 and N3 stations with a median survival
of 20, 22 and 25 months, respectively (P = 0.66).
Table 2 Type of surgical intervention in patients included in the study
Surgical procedure N %
Common bile duct resection 7 11.3
Common bile duct with caudate lobe resection 1 1.6
Bisegmentectomy 2 3.2
Bisegmentectomy with caudate lobe resection 1 1.6
Mesohepatectomy and caudate lobe resection (S1 + S4 + S5 + S8) 1 1.6
Left hepatectomy (S2 + S3 + S4) 4 6.5
Left hepatectomy and caudate lobe resection (S1 + S2 + S3 + S4) 23 37.1
Left trisectionectomy (S1 + S2 + S3 + S4 + S5 + S8) 2 3.2
Right hepatectomy (S5 + S6 + S7 + S8) 2 3.2
Right hepatectomy and caudate lobe resection (S1 + S5 + S6 + S7 + S8) 10 16.1
Right trisectionectomy and caudate lobe resection (S1 + S4 + S5 + S6 + S7 + S8) 9 14.6
Total 62 100.0
Table 3 Survival analysis for different subgroups of patients included into the study: number of patients, median survival with 95%
confidence interval (CI), actuarial 3- and 5-year survival and P-value of the log rank test
Variable n Median survival
(Months)
95% CI 3-y surv
(%)
5-y surv
(%)
P
Overall 62 21.9 18.2–25.5 30 15 –
LN 0.032
N0 32 41.9 13.3–70.4 50 25
N+ 21 22.7 18.2–27.2 0 0
LN harvested 0.001
0 LN 9 3 1.0–5.9 0 0
1–3 LN 18 18.5 12.7–24.2 25 16
>3 LN 35 28.8 17.0–46.6 41 16
Positive LN 0.721
1–3 N+ 14 22.7 10.1–35.3 0 0
>3 N+ 7 25 – 0 0
Negative LN 0.152
1–3 N0 examined 14 18.5 13.1–23.8 31 20
>3 N0 examined 18 43.1 25.6–60.5 68 27
LNR 0.031
0.25 42 26 16.2–35.8 44 22.5
>0.25 9 22.7 1.0–45.0 0 0
LN, lymph node; LNR, lymph node ratio.
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In the group with no LN metastases patients with 1–3 LN
harvested showed a median survival of 18.5 compared with 43.1
months for patients with more than 3 LN examinated, the differ-
ence did not reach statistical significance (P = 0.152) (Table 3).
In order to evaluate the prognostic significance of LN
metastases and its relationship with the total number of LN har-
vested, we evaluated the LNR with a cut-off value of 0.25.
Multivariate survival analysis using Cox’s proportional hazards
model (Table 4) showed that factors significantly realted with sur-
vival were surgical radicality and LNR with hazard ratios of 4.40
(95% CI 1.19–16.24) and 3.16 (1.16–8.62), respectively.
Discussion
LN metastases are a major prognostic factor in the treatment of
perhilar cholangiocarcinoma; 30–50% of patients who undergo
surgical resection will have nodal involvement.2,16–19
Within the literature 5-year survival for positive node patients
does not reach 20%,4–8 and similar findings have been shown in
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Figure 1 Survival curves in the subgroups by total number of har-
vested lymph nodes (LN). Survival was significantly related to the
number of harvested LN (P-value of the log-rank test = 0.01)
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Figure 2 Survival curves in the subgroups by lymph node (LN)
status. Survival was significantly shorter in N+ patients (P = 0.03)
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Figure 3 Survival curves in the subgroups by lymph node ratio
(LNR). Survival was significantly longer in patients with LNR lower or
equal to 0.25 (P = 0.03)
Table 4 Multivariate survival analysis using Cox's proportional
hazards model: estimated hazard ratios, 95% confidence interval
(CI) and P-values of the hypothesis test about independence
between factors and survival
Variable HR 95% CI P
LNR >0.25 vs. 0.25 3.16 1.16–8.62 0.024
R1 vs. R0 4.40 1.19–16.24 0.026
TNM stage 1.52 0.78–3.01 0.229
Macroscopic vascular invasion 0.83 0.27–2.47 0.741
Perineural invasion 0.31 0.79–1.27 0.105
LNR, lymph node ratio.
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the present study. The prevalence of non-regional lymphnode
metastases, defined asM1 according to the UICC TNM, is not well
known in hilar cholangiocarcinoma as systematic dissection of
non-regional lymphnodes is not routinely performed in the
majority of centres. Kitagawa et al. identified a prevalence of posi-
tive para-aortic lymph nodes of 17% and reported a 5-year sur-
vival of 14% in this group of patients.17 Moreover, 5-year survival
decreased to 0% in patients with macroscopically andmicroscopi-
cally positive para-aortic lymph nodes.17
The extent of LN dissection is still a matter of debate in litera-
ture. According to 7th edn the AJCC/UICC Guidelines at least
three LN should be harvested for adequate staging of perhilar
cholangiocarcinoma.20 In a recent study, Ito et al. demonstrated
the relationship between the total number of LN examined and
survival in patients without LNmetastases.21 Ito et al. identified an
optimum cut-off value for hilar cholangiocarcinoma of seven LN
for a higher disease-specific survival for N0 patients.21 In the
current study the median number of examined lymphnodes was
grater than 7, a result that is similar to other data in literature.12
The multi-istitutional US study based upon the Surveillance,
Epidemiology and End Results (SEER) database identified a sig-
nificant relationship between the number of examined lymph-
nodes in N0 patients submitted for surgical resection for
extrahepatic bile duct cancer, gallbladder cancer or ampullary
carcinoma.22 The authors reported a median survival of 21 and 34
months for patients with 1 to 2 and more than 10 lymph nodes
examined, respectively.22 Moreover, the authors identified a rela-
tionship between the number of positive LN and survival.22
However, the major limitation of this study was that the authors
included different types of tumours with known different biologi-
cal behaviour.22
This issue had not been clearly demonstrated in patient with
peri-hilar cholangiocarcinoma.
In the present study the value of systematic regional lym-
phadenectomy has been confirmed. Patients with more than three
LN harvested showed longer survival. Within the literature no
data are avaible regarding the therapeutic value of lymphadenec-
tomy in the bile duct and liver cancers but a systematic dissection
of regional LN improves staging of the disease, statification of
patients and could increase survival in selected groups of patients.
In order to investigate the prognostic value of the number of
positive LN and its relationship with the total number of LN
harvested the present study also evaluated the LNR.
LNR has demonstrated its prognostic value in oesophageal,
gastric, colorectal and pancreatic cancer.9–11 Recently the prognos-
tic value of LNR was also demonstred in intrahepatic cholangio-
carcinoma.12 To the authors knowledge no studies have analysed
this issue in perihilar cholangiocarcinoma. The present study has
identified a relationship between survival and LNR demonstrating
the prognostic value of this factor. Moreover in our sample a
cut-off value of 0.25 demonstrated its prognostic value in univari-
ate and multivariate analysis. The LNR can be applied in clinical
practice to stratify more accurately patients after surgical resec-
tion. The current analysis also demonstrated that patients with LN
metastases can have long-term survival if LNR is below 0.25.
Conclusions
LN metastases is a major prognostic factors for survival after
surgical resection of PCC. The number of LN harvested and LNR
showed a prognostic value. Likewise of other gastrointestinal
tumours, the present study identifies the prognostic role of LNR
also in PCC.
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